Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Investments aim to strengthen capabilities of DuPont Liveo healthcare silicone solutions

By Heather Hall | November 2, 2020

DuPont (NYSE: DD), a producer of silicone-based technology and innovations for healthcare, is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo brand healthcare silicone solutions. Underscoring its long-term commitment to the healthcare industry – and confidence in its growth potential – DuPont is investing in innovation, as well as in manufacturing capabilities. These investments are focused on accelerating business growth, addressing key industry challenges arising from global megatrends and continually improving and expanding DuPont’s ability to serve customers.

“We are working in close collaboration with our key customers to help support and drive their leadership in key healthcare industry market segments,” said DuPont Liveo Healthcare Global Business Director Eugenio Toccalino. “As a leader in Biopharma Processing, Pharma Solutions and Medical Devices, we want to enable our customers to achieve a competitive edge and grow their business in these segments. Our customers fully appreciate and reward the value of our specialists and our full commitment to the needs of the healthcare industry all the way down to the patients.”

To support customer growth and accelerate new product introductions, the targeted investments include increasing supply capacities with manufacturing improvements at DuPont’s Healthcare Industries Materials Site (HIMS) in Hemlock, Mich. Notable upgrades include extrusion capacity expansion for tubing, a new ISO 7 cleanroom and ongoing elastomer capacity expansions with new mixing equipment for liquid silicone rubber (LSR) and high-consistency rubber (HCR).

These investments are critical for DuPont Liveo to continue addressing the key challenges and opportunities in three primary healthcare market segments, namely:

  •   Biopharma Processing, to enable cost-effective, safe manufacturing of biologics used in innovative drugs and vaccines with a wide range of Liveo pharma tubing and overmolded assemblies.
  •   Pharmaceutical Solutions, to enable safe, effective new therapeutic drug delivery routes with a unique offering in topical and transdermal solutions, and gastrointestinal active pharmaceutical ingredients.
  •    Medical Devices, to enable safe, convenient and effective diagnostics, monitoring and treatment at the point of care with a broadening range of specialty medical adhesives and elastomers to support the trend for connected devices and wearables.

“Without question, these investments in the future of healthcare will help strengthen and grow the value of our DuPont Liveo brand healthcare silicone solutions,” Toccalino says. “We believe that DuPont Healthcare will have a positive impact on every level of the healthcare industry value chain.”

For more information, visit liveo.dupont.com

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE